Justin Bowers
Stock Analyst at Deutsche Bank
(1.76)
# 3,215
Out of 4,944 analysts
51
Total ratings
35.48%
Success rate
1.73%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $296.83 | +6.12% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $468.00 | -8.12% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $190.23 | +39.31% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $7.84 | +193.37% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.86 | +26.86% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $100.98 | +0.02% | 11 | Jul 31, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $13.57 | +84.23% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $127.15 | +21.90% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $484.79 | +25.83% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $54.71 | +49.88% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $13.07 | +91.28% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.75 | +518.18% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $176.29 | +70.17% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $209.14 | +31.49% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $246.22 | +1.54% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $155.00 | +87.10% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $12.67 | +263.06% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $296.83
Upside: +6.12%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $468.00
Upside: -8.12%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $190.23
Upside: +39.31%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $7.84
Upside: +193.37%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.86
Upside: +26.86%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $100.98
Upside: +0.02%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $13.57
Upside: +84.23%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $127.15
Upside: +21.90%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $484.79
Upside: +25.83%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $54.71
Upside: +49.88%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $13.07
Upside: +91.28%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.75
Upside: +518.18%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $176.29
Upside: +70.17%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $209.14
Upside: +31.49%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $246.22
Upside: +1.54%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $155.00
Upside: +87.10%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $12.67
Upside: +263.06%